ClinConnect ClinConnect Logo
Search / Trial NCT06532994

Predictive Algorithms for Critical Rehabilitation Outcomes

Launched by WUHAN UNIVERSITY · Jul 29, 2024

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how to identify which patients who have been on a breathing machine (mechanical ventilation) in the Intensive Care Unit (ICU) might benefit from early rehabilitation (therapy to help them recover) after their stay. Researchers want to collect information from patients who have received this early rehabilitation and use it to create a prediction model. This model will help doctors understand which patients are likely to improve with early therapy, aiming to reduce complications and enhance their quality of life.

To be eligible for this trial, participants need to be over 18 years old, have received mechanical ventilation while in the ICU, and undergone specific early rehabilitation interventions, such as therapies to help with consciousness or movement. They also must not have experienced any life-threatening events during their ICU stay and need consent from themselves or their family to participate. If you or a loved one fits these criteria, joining this study could provide valuable insights into recovery after serious illness. Participants will undergo assessments and therapies, helping researchers understand the best ways to support recovery for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age older than 18 years;
  • 2. Received mechanical ventilation, including endotracheal intubation and tracheostomy, during ICU admission;
  • 3. Met the rehabilitation intervention indications outlined in the "Chinese Expert Consensus on Neurocritical Rehabilitation" during ICU admission and underwent corresponding early rehabilitation interventions, including but not limited to arousal therapy for consciousness disorders, early active/passive mobilization, comprehensive pulmonary rehabilitation, etc.;
  • 4. No mortality events occurred during ICU admission;
  • 5. Informed consent form signed by family members or the patient.
  • Exclusion Criteria:
  • 1. Pediatric patients under 18 years of age;
  • 2. Hospitalized patients in the ICU who did not receive mechanical ventilation;
  • 3. Patients in the ICU who did not undergo early rehabilitation interventions;
  • 4. mortality events occurred during ICU admission;
  • 5. Patients transferred out of the ICU due to treatment abandonment by family members;
  • 6. Family refusal to sign the informed consent form or patient refusal to sign the informed consent form when conscious and competent.

About Wuhan University

Wuhan University, a prestigious research institution located in Wuhan, China, is renowned for its commitment to advancing medical science and improving public health through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive academic resources and expertise to conduct rigorous clinical studies aimed at exploring novel therapies and interventions. The institution is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring the safety and well-being of participants while contributing valuable insights to the global medical community.

Locations

Wuhan, , China

Wuhan, 湖北, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported